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Leptin, a peptide hormone secreted by adipocytes in proportion of the amount of 
energy stored in fat, plays a central role in regulating human energy homeostasis. 
In addition, leptin plays a significant permissive role in the physiological regula-
tion of several neuroendocrine axes, including the hypothalamic-pituitary-gonadal, 
-thyroid, -growth hormone, and -adrenal axes. Decreased levels of leptin, also 
known as hypoleptinemia, signal to the brain a state of energy deprivation. Hypo-
leptinemia can be a congenital or acquired condition, and is associated with altera-
tions of the aforementioned axes aimed at promoting survival. More specifically, 
gonadotropin levels decrease and become less pulsatile under conditions of energy 
deprivation, and these changes can be at least partially reversed through leptin ad-
ministration in physiological replacement doses. Similarly, leptin deficiency is as-
sociated with thyroid axis abnormalities including abnormal levels of thyrotropin-
releasing hormone, and leptin administration may at least partially attenuate this 
effect. Leptin deficiency results in decreased insulin-like growth factor 1 levels 
which can be partially ameliorated through leptin administration, and leptin ap-
pears to have a much more pronounced effect on the growth of rodents than that of 
humans. Similarly, adrenal axis function is regulated more tightly by low leptin in 
rodents than in humans. In addition to congenital leptin deficiency, conditions that 
may be associated with decreased leptin levels include hypothalamic amenorrhea, 
anorexia nervosa, and congenital or acquired lipodystrophy syndromes. Accumu-
lating evidence from proof of concept studies suggests that leptin administration, 
in replacement doses, may ameliorate neuroendocrine abnormalities in individuals 
who suffer from these conditions.
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INTRODUCTION
Leptin, an adipocyte-secreted hormone, was first discovered in 1994 through posi-
tional cloning of the ob/ob mouse model of obesity.1 Since then, much has been 
discovered about leptin’s role in regulating energy homeostasis, neuroendocrine, 
and immune functions. Leptin is secreted in direct proportion to the amount of en-
ergy stored in adipose tissue, and circulating leptin levels serve as a peripheral sig-Sami M. Khan, et al.
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the hypothalamus,27,28 kidneys, lungs,29 lymphocytes,28,30-32 
adipose tissue,21,33,34 prostate, ovaries, liver, small intestines, 
and heart.16,35 There are at least six isoforms of the murine 
leptin receptor,36 whereas in humans, only four alternatively 
spliced isoforms have been described.37,38 The ObRb recep-
tor, the long form of the leptin receptor, is considered the 
active leptin receptor and is highly expressed in the hypo-
thalamus, including in nuclei associated with body weight 
control.29
Circulating leptin levels in humans
Leptin levels in the blood stream display a circadian pattern 
such that leptin concentration is at the lowest point between 
early afternoon and mid-afternoon and is at its highest point 
between midnight and early morning.39,40 Furthermore, 
leptin secretion appears to be pulsatile.11 Though the pulsa-
tility of leptin secretion is similar in obese and in lean indi-
viduals, the amplitude of leptin pulses is greater among 
obese individuals.11
Several factors contribute to the inter-individual variabili-
ty of leptin levels in humans, including gender and total 
body fat mass.41 Leptin levels display sexual dimorphism, 
with women having higher levels than men even after con-
trolling for adiposity.42 Sex hormones such as testosterone43 
and estrogen44,45 explain some of the gender variation in 
leptin levels. Among women, leptin levels appear to be at 
their highest level during the luteal phase of the menstrual 
cycle.46 Distribution of fat also plays a role in variability of 
leptin levels; subcutaneous fat appears to produce more 
leptin than omental fat.47 
NEUROENDOCRINE FUNCTIONS OF 
LEPTIN IN HUMANS
Data on the neuroendocrine functions of leptin in humans 
emanate mainly from case reports of congenital leptin defi-
ciency and leptin administration to these individuals,48-50 as 
well as from observational and interventional physiology 
studies involving fasting and/or weight loss in normal sub-
jects followed by leptin administration.7,8,51,52 In a direct ex-
tension of these studies, leptin physiology and pathophysi-
ology has also been studied using various disease states as 
experimental models. These include conditions associated 
with relative leptin deficiency, such as hypothalamic amen-
orrhea and lipodystrophies.48,53,54 We summarize findings 
from these studies in the following paragraphs.
nal to the central nervous system about the amount of ener-
gy reserves available for reproductive and other essential 
functions.2 Thus, circulating leptin levels dictate the body’s 
energy homeostasis and neuroendocrine, immune as well 
as metabolic function.3-5 More recently, human and rodent 
studies have demonstrated that leptin plays an important 
role in regulating neuroendocrine axes such as the hypotha-
lamic-pituitary-gonadal axis,6-8 the thyroid axis,6,7 the growth 
hormone axis,7,9 and the adrenal axis.10,11 Leptin levels are 
also influenced by several other factors including acute 
change in energy intake; leptin levels decrease in response 
to acute and chronic energy deprivation.7,8,12 It appears that 
leptin may be especially important in mediating neuroendo-
crine adaptations that act in a concerted manner to conserve 
energy.6-8 We review herein the current state of knowledge 
about the effects of leptin, leptin deprivation, and leptin re-
placement on these neuroendocrine axes.
Biology of leptin; an overview
Leptin, the product of the ob gene in rodents1 and the LEP 
gene in humans, is a 167-amino acid, 16 kDalton, adipo-
cyte-secreted hormone. It structurally resembles a cytokine 
and as it was one of the first adipocyte-secreted hormones 
to be discovered with this cytokine-like structure, it is the 
prototype of the adipocytokine proteins. Orthologs of leptin 
with slightly varied amino acid sequences but conserved 
functional properties and tertiary structure have been found 
in several species including fish and reptiles.13 Leptin is 
produced primarily by the white adipose tissue, but is also 
expressed in other tissues such as the brown adipose tis-
sue,14 the primary and secondary lymphoid organs,15 the 
bone marrow, the mammary epithelium, the ovaries, the 
skeletal muscle, and the placenta to mention a few.16 Leptin 
levels in humans are secreted in proportion to energy stored 
in fat (total body fat mass).17,18 Acute changes in caloric in-
take, mainly acute decreases in food intake, have been shown 
to have a dramatic effect on circulating leptin concentra-
tions. For example, fasting for one or three days results in a 
marked decrease of leptin levels (by 50% and 80% respec-
tively).7,8,12 Leptin levels in humans are also influenced by 
sex steroid levels,3,19-21 thyroid hormones, cytokines, and 
other factors to a lesser degree than the factors mentioned 
above.22-24 
Leptin exerts its effects through binding and activating 
specific leptin receptors, which are coded for by the db 
gene in mice25 and the LEPR gene in humans.26 These re-
ceptors exist both in the central nervous system, especially Neuroendocrine Functions of Leptin
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mice express Kiss1 mRNA to a lesser degree than do their 
wild-type counterparts.67 The expression of Kiss1 mRNA is 
partially restored with the administration of exogenously 
administered leptin67 whereas exogenously administered 
kisspeptin to rodents that are relatively leptin deficient stim-
ulates the secretion of GnRH71 and increases levels of LH, 
follicle-stimulating hormone,72,73 and testosterone.73 Popula-
tions of neurons with leptin receptors in brain regions such 
as the hypothalamic ventral premammillary nucleus and the 
preoptic region have been found in close proximity to both 
Kiss1 and GnRH neurons.74 Although leptin’s initiation of 
puberty in mice requires a functional ventral premammilla-
ry nucleus, this does not appear to require the action of 
Kiss1 mRNA expressing neurons.75
THYROID AXIS
Similar to leptin, thyroid-stimulating hormone (TSH) has a 
pulsatile and circadian pattern of secretion, and we have 
found that both hormones have similar circadian patterns.76 
In congenitally leptin-deficient individuals, we have ob-
served that TSH secretion is disorganized.76 It has also been 
reported that leptin-deficient children exhibit an increase in 
triiodothyronine (T3) and thyroxine (T4), though not in TSH, 
after leptin therapy in an uncontrolled interventional study;49 
however, one boy, one man, and two women, all of whom 
had congenital leptin-deficiency, demonstrated normal thy-
roid function whether or not they were undergoing leptin 
replacement.50 
In rodents, leptin deficient ob/ob mice demonstrate much 
more pronounced thyroid disorders, including hypothalamic 
hypothyroidism since birth.77 Similarly, fasting decreases se-
rum levels of T4 in mice, though this effect can be amelio-
rated through leptin administration.6 Leptin regulates thyro-
tropin-releasing hormone levels by increasing pro-TRH 
gene expression in neurons in the paraventricular nucleus of 
the hypothalamus,78 probably through the central melano-
cortin system.79 Leptin also stimulates the expression of pro-
hormone convertases 1 and 2, which cleave pro-TRH in or-
der to produce TRH in the paraventricular nucleus.80
To directly test the role of leptin in regulating thyroid func-
tion in humans, we administered leptin in the context of a ran-
domized, placebo controlled interventional study involving 
fasting of normal-weight men for 72 hours. Fasting-induced 
hypoleptinemia resulted in altered TSH levels and secretion 
patterns and leptin administration ameliorated the degree to 
GONADAL  AXIS
Humans with genetic mutations that lead to congenital 
leptin deficiency experience hypogonadotropic hypogonad-
ism and failure to undergo puberty;55 the latter is restored 
by leptin administration in replacement doses.48,49,56 These 
data in the extremely rare subjects with congenital leptin 
deficiency are consistent with our finding that a rise in 
leptin levels precedes the onset of puberty in normal boys.57 
Even in rodents, exogenous leptin administration results in 
earlier onset of markers of puberty including vaginal open-
ing,58 and leptin antibodies appear to inhibit pubertal onset 
in female rats.59 Although ob/ob mice have complete leptin 
deficiency and are infertile, female ob/ob mice can ovulate 
and give birth if they are treated with leptin in replacement 
doses,60 which stimulates the secretion of luteinizing hor-
mone (LH) in vivo.61 In mice, fasting-induced hypolepti-
nemia also diminishes the levels of gonadotropins and im-
pairs the reproductive function and sex hormone levels of 
these mice; however, leptin administration restores testos-
terone levels in male mice, estrous cycles in female mice, 
and LH levels in both.6
In a follow-up to our rodent experiments and observation-
al studies in humans, we have also demonstrated that caloric 
deprivation of normal-weight men decreases testosterone 
levels as well as LH pulsatility, effects that can be fully nor-
malized by administering leptin in physiological replace-
ment doses.7,62 Similarly, caloric deprivation that leads to 
partial leptin deficiency in normal-weight women decreases 
their LH peak frequency, and this effect can be reversed 
through leptin administration.8 Leptin’s effect on luteinizing 
hormone secretion appears to proceed via an indirect mech-
anism, as neurons that secrete gonadotropin-releasing hor-
mone (GnRH) do not have leptin receptors.63 There is evi-
dence that leptin may act on groups of neurons that in turn 
provide input to populations of GnRH secreting neurons in 
regions of the brain such the preoptic area.21,64,65 These 
groups of neurons may include agouti-related peptide/neuro-
peptide Y and proopiomelanocortin neurons64 as well as 
neurons in the arcuate nucleus that express kisspeptin, bra-
dykinin, and dynorphin, that regulate GnRH secreting neu-
rons66 either directly or through KiSS-1 neurons.67
A well-studied mediator of the relationship between leptin 
and reproduction is kisspeptin. This protein is a product of 
the Kiss1 gene.68 Kiss1 mRNA expression is reduced in the 
caudal hypothalamus of fasting female rats69,70 and ob/ob Sami M. Khan, et al.
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leptin gene demonstrate normal growth velocity in child-
hood48,49 although their final height is decreased due to the 
lack of pubertal growth spurt.83 We have proposed on the 
basis of the above and other experimental data from our 
own physiology studies in humans that leptin may regulate 
growth hormone’s ability to stimulate the secretion of insu-
lin-like growth factor 1 (IGF-1) as well as the corresponding 
binding proteins in the periphery as opposed to acting di-
rectly on pituitary secretion of growth hormone itself.84 
We have shown by studying a group of normal-weight 
men who became truly hypoleptinemic through prolonged 
fasting that leptin administration tends to restore total IGF-1 
levels, which are decreased due to caloric deprivation.7 In 
normal weight women, though, we found that leptin re-
placement did not significantly normalize IGF-1 levels.8 
Again, this was interpreted as illustrative of leptin having a 
threshold for neuroendocrine regulation as the men’s leptin 
levels dropped below 3 ng/mL whereas the women’s aver-
age leptin level did not.81 Similarly, administering leptin to 
euleptinemic subjects undergoing a 6-month-long mild hy-
pocaloric diet did not appear to alter levels of the circulat-
ing levels of IGF-1 or other hormones in the IGF axis.82
ADRENAL AXIS
In vitro evidence indicates that corticotropin-releasing hor-
mone is released in response to leptin in a dose-dependent 
manner10 and suggests that leptin decreases the secretion of 
corticosterone from cells of rat adrenal cortex.85 Additionally, 
leptin decreases the degree to which stress increases ACTH 
and corticosterone levels.86
On the basis of very small and non-randomized studies, it 
has been suggested that the adrenal axis of individuals with 
mutated leptin or leptin receptor genes may not be signifi-
cantly impaired.26,48,49 Similarly, leptin administration in a 
group of men who became hypoleptinemic in response to 
fasting for 72 hours did not appear to have a major effect on 
cortisol secretion.7 Likewise, leptin administration did not 
attenuate significantly the activation of the adrenal axis in a 
similar study of fasting women.8 In contrast, in the context 
of a larger randomized placebo-controlled study, we found 
that women with hypothalamic amenorrhea who were hy-
percortisolemic did experience a statistically significant de-
crease in cortisol levels after they were treated with replace-
ment doses of metreleptin.87 Along the same lines, we have 
reported that there appears to be an inverse relationship be-
which caloric deprivation altered TSH secretion patterns and 
levels.7 In contrast to men, in whom significant hypolepti-
nemia was induced (levels less than 2-3 ng/mL), similarly 
pronounced effects of leptin administration were not seen in 
a similar study on normal-weight women8 in whom leptin 
levels were decreased but remained within normal limits. We 
proposed that the reason for the discrepant results between 
these two otherwise similar studies could be the fact that men 
experienced a decrease in leptin levels to an average of 0.27 
ng/mL (much lower than the lower normal level in our labo-
ratory, 3 ng/mL).7 In contrast, leptin levels dropped to an av-
erage level of approximately 3 ng/mL in women8 and thus 
we suggested that leptin appears to have a threshold level for 
regulation of TSH.81 In contrast to TSH, T3 and T4 were 
much less regulated in humans than in rodents. 
These data, taken together, suggest that although leptin 
may have a significant effect in regulating the secretion pat-
tern of TSH in humans, its role in regulating circulating lev-
els of T3 and T4 may not be as important in humans as it is 
in rodents and may be different in complete leptin deficien-
cy than in relative, acute hypoleptinemia.21,65,81 
A subsequent interventional but non-randomized study 
focused on both lean and obese participants who were stud-
ied before and after they had lost 10% of their body weight 
(and thus became relatively hypoleptinemic) over the course 
of an average of eight weeks.51 Though all participants ex-
perienced decreased levels of leptin, obese subjects still had 
relatively higher levels, which ranged from 10 ng/mL up to 
60 ng/mL.51 Levels of TSH, T3, and T4 were reportedly all 
decreased, though leptin replacement only increased T3 
and T4 levels in these subjects.51 The authors of this study 
suggest that leptin may increase the bioactivity of TSH or 
stimulate T4 secretion, but these results from this non-ran-
domized study remain to be replicated by future random-
ized studies involving administration of leptin in physiolog-
ical replacement doses.51 We have recently reported that 
administering leptin in pharmacological doses to subjects 
undergoing a 6-month-long mild hypocaloric diet does not 
appear to alter levels of the circulating hormones of the thy-
roid axis but doses administered were supraphysiological 
and may have thus suppressed leptin receptors leading to 
suboptimal results.82
GROWTH HORMONE AXIS
Humans who are leptin-deficient due to mutations of the Neuroendocrine Functions of Leptin
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teocalcin, two bone formation markers.54 More definitive 
results in terms of changes in overall or regional bone min-
eral content or density were reported in the nine-month long 
randomized placebo-controlled study.87 In this study, six 
women underwent nine months of double-blind leptin ad-
ministration and then elected to receive an additional year of 
open-label leptin administration; these women experienced 
significant gains in bone mineral content and density.87
Anorexia nervosa
Anorexia nervosa is associated with hypoleptinemia.53 Among 
amenorrheic anorexic women with who have gained weight, 
circulating leptin levels are higher in those whose menses 
had resumed than in those who had remained amenorrheic.93 
Unfortunately, there may be mild weight and/or fat loss with 
leptin replacement in lean women,54,92 which may be a po-
tential reason not to administer leptin to anorexic women.
Lipodystrophy
Lipodystrophy is a condition characterized by abnormal 
distribution of adipose tissue. It is either inherited, in a very 
small number of patients, or can be acquired. The latter is 
much more frequent and most often occurs in HIV-positive 
subjects being treated with highly-active antiretroviral ther-
apy for human immunodeficiency virus (HIV) infection.94 
Subjects with significant degrees of lipodystrophy have 
lower leptin levels than unaffected subjects.95,96 Leptin ad-
ministration in replacement doses is associated with nor-
malization of neuroendocrine parameters in subjects who 
have lipodystrophy.97 Additionally, and probably even more 
importantly, leptin administration in replacement doses to 
subjects with lipodystrophy improves their metabolic abnor-
malities; including hypertriglyceridemia and impaired glu-
cose control which often are resistant to maximum doses of 
insulin sensitizers or very high doses of insulin.98,99 The de-
velopment of anti-leptin antibodies has been considered by 
many as a factor that may limit the use of this medication in 
humans but data remain inconclusive.100,101
CONCLUSION
　　　
In conclusion, it appears that leptin regulates neuroendo-
crine function in humans and has a special role in mediat-
ing the neuroendocrine response to energy deprivation. Di-
rections for future research include further elucidating the 
anatomical connections between energy homeostasis and 
tween healthy men’s fluctuations in circulating levels of 
leptin and both cortisol and ACTH.11 Thus, the effect of 
leptin to regulate the adrenal axis in humans is rather small 
in magnitude and thus can be detected only in larger, ran-
domized studies. 
POTENTIAL APPLICATIONS OF LEPTIN 
IN HUMAN PATHOPHYSIOLOGY AND 
THERAPEUTICS 
Congenital leptin deficiency
Mutations of the leptin gene result in congenital leptin defi-
ciency, a rare condition in humans seen more commonly in 
populations where consanguineous marriage is relatively 
more common.88 Congenital leptin deficiency leads to obe-
sity, which arises early in life, due to uncontrollable hyper-
phagia.89 It is also accompanied by neuroendocrine abnor-
malities such hypothalamic hypogonadism and pubertal 
failure55 which can be treated with leptin administration in 
replacement doses.48,49,56 As mentioned above, these indi-
viduals may have an impaired pituitary-thyroid axis (though 
one case series did not find abnormal thyroid function50), 
with increased T3 and T4 levels and unchanged TSH levels 
after leptin replacement.49 Leptin is currently available on a 
compassionate basis for the treatment of morbid obesity 
and hypothalamic hypogonadism of these subjects. 
Hypothalamic amenorrhea
Hypothalamic amenorrhea (HA) caused by an imbalance 
between energy expenditure and energy intake associated 
with excessive stress, excessive exercise, or inadequate food 
intake leads to significant neuroendocrine abnormalities, in-
fertility and osteoporosis/stress fractures.90 In association 
with low fat mass, women with HA have abnormally low 
levels of leptin.91 We have reported that administration of 
leptin, in replacement doses, may lead to normalization of 
neuroendocrine action in women with hypothalamic amen-
orrhea.54 Leptin replacement normalized LH levels and pul-
satility within weeks and ovulation within months in an open 
label study with a course of treatment of ten weeks.54 More-
over, in a subsequent placebo-controlled, double-blind, ran-
domized study with a larger sample size we confirmed these 
results using a course of treatment of nine months.92
The aforementioned ten-week study of leptin replace-
ment in women with hypothalamic amenorrhea yielded in-
creased levels of bone-specific alkaline phosphatase and os-Sami M. Khan, et al.
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related to pituitary-adrenal function. Nat Med 1997;3:575-9.
12. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on se-
rum leptin in normal human subjects. J Clin Endocrinol Metab 
1996;81:3419-23.
13. Denver RJ, Bonett RM, Boorse GC. Evolution of leptin structure 
and function. Neuroendocrinology 2011;94:21-38. 
14. Trayhurn P, Duncan JS, Hoggard N, Rayner DV. Regulation of 
leptin production: a dominant role for the sympathetic nervous 
system? Proc Nutr Soc 1998;57:413-9.
15. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. 
J Immunol 2005;174:3137-42.
16. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of 
its peripheral actions and interactions. Int J Obes Relat Metab 
Disord 2002;26:1407-33.
17. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens 
TW, Nyce MR, et al. Serum immunoreactive-leptin concentra-
tions in normal-weight and obese humans. N Engl J Med 1996; 
334:292-5.
18. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-
Zacas D, Mantzoros CS. Body fat mass and macronutrient intake 
in relation to circulating soluble leptin receptor, free leptin index, 
adiponectin, and resistin concentrations in healthy humans. J 
Clin Endocrinol Metab 2003;88:1730-6.
19. Mantzoros CS, Flier JS. Editorial: leptin as a therapeutic agent--
trials and tribulations. J Clin Endocrinol Metab 2000;85:4000-2.
20. Mantzoros CS. Role of leptin in reproduction. Ann N Y Acad Sci 
2000;900:174-83.
21. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative re-
view: the role of leptin in human physiology: emerging clinical 
applications. Ann Intern Med 2010;152:93-100.
22. Mullington JM, Chan JL, Van Dongen HP, Szuba MP, Samaras J, 
Price NJ, et al. Sleep loss reduces diurnal rhythm amplitude of 
leptin in healthy men. J Neuroendocrinol 2003;15:851-4.
23. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse meta-
bolic and cardiovascular consequences of circadian misalign-
ment. Proc Natl Acad Sci U S A 2009;106:4453-8. 
24. Mantzoros CS, Liolios AD, Tritos NA, Kaklamani VG, Doulger-
akis DE, Griveas I, et al. Circulating insulin concentrations, 
smoking, and alcohol intake are important independent predic-
tors of leptin in young healthy men. Obes Res 1998;6:179-86.
25. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, 
et al. Evidence that the diabetes gene encodes the leptin receptor: 
identification of a mutation in the leptin receptor gene in db/db 
mice. Cell 1996;84:491-5.
26. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, 
et al. A mutation in the human leptin receptor gene causes obesi-
ty and pituitary dysfunction. Nature 1998;392:398-401.
27. Mantzoros CS, Moschos SJ. Leptin: in search of role(s) in hu-
man physiology and pathophysiology. Clin Endocrinol (Oxf) 
1998;49:551-67.
28. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, De-
vos R, et al. Identification and expression cloning of a leptin re-
ceptor, OB-R. Cell 1995;83:1263-71.
29. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R, et al. Ana-
tomic localization of alternatively spliced leptin receptors (Ob-R) 
in mouse brain and other tissues. Proc Natl Acad Sci U S A 1997; 
94:7001-5.
30. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, 
Kim H, et al. The full-length leptin receptor has signaling capa-
bilities of interleukin 6-type cytokine receptors. Proc Natl Acad 
neuroendocrine functions and the specific molecular mech-
anisms underlying these connections.
Additionally, it appears that leptin levels are decreased in 
conditions such as congenital leptin deficiency, hypothalam-
ic amenorrhea, anorexia nervosa, and lipoatrophy, condi-
tions in which a leptin measurement in the blood could pro-
vide important novel diagnostic information. Small-scale 
proof-of-concept studies have shown that several of the neu-
roendocrine and other abnormalities associated with these 
conditions can be ameliorated via leptin therapy in replace-
ment doses. Future research should involve larger-scale 
phase III placebo-controlled leptin administration trials to 
fully establish leptin’s therapeutic role in disease states asso-
ciated with leptin deficiency.
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